NASDAQ · Analyst Forecast

Journey Medical Corporation (DERM) Stock Forecast & Price Target

$3.90 NASDAQ: DERM Market Cap $110.08M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Journey Medical Corporation (DERM), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Journey Medical Corporation, analysts forecast revenue rising from $64.65M in 2025 to $172.33M in 2030; the average estimate for 2030 earnings per share is $1.13; with published estimates ranging from $1.02 to $1.23; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$3.90
Consensus targetThe average of the price targets analysts have published.$11.75
Median targetThe middle target, less affected by a single outlier.$11.75
Highest targetThe most optimistic published target.$13.00
Lowest targetThe most pessimistic published target.$10.50
Difference from priceHow far the consensus target sits from today’s price.+201.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$63.89M$64.65M$65.41M3
2026$71.07M$74.51M$77.94M2
2027$91.21M$104.78M$118.34M2
2028$138.39M$152.35M$166.31M2
2029$139.35M$149.96M$161.10M1
2030$160.13M$172.33M$185.12M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.53−$0.48−$0.433
2026−$0.32−$0.15$0.022
2027$0.06$0.32$0.572
2028$0.49$0.54$0.592
2029$0.78$0.86$0.941
2030$1.02$1.13$1.231

Journey Medical Corporation (DERM) forecast — frequently asked questions

What is the analyst price target for Journey Medical Corporation?

Analysts covering Journey Medical Corporation (DERM) have a consensus price target of $11.75, 201.3% above the current price of $3.90. Published targets range from $10.50 to $13.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Journey Medical Corporation's earnings?

The average analyst estimate for Journey Medical Corporation (DERM) earnings per share in 2030 is 1.13, with individual estimates between 1.02 and 1.23.

How much revenue is Journey Medical Corporation expected to make?

Analysts forecast Journey Medical Corporation (DERM) revenue of $172.33M in 2030, based on 1 published estimates.

How many analysts cover DERM?

3 analysts contribute estimates for Journey Medical Corporation (DERM). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastRDY forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.